The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA AMERICAN DEPOSITARY SHARES | ADRS | 00370M103 | 46,332,959 | 6,056,596 | SH | SOLE | 6,056,596 | 0 | 0 | |||
| ADVERUM BIOTECHNOLOGIES INC | COMM | 00773U207 | 3,862,436 | 1,796,482 | SH | SOLE | 1,796,482 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COMM | 03237H101 | 38,099,835 | 5,943,812 | SH | SOLE | 5,943,812 | 0 | 0 | |||
| Agios Pharmaceuticals, Inc. | COMM | 00847X104 | 23,182,320 | 697,003 | SH | SOLE | 697,003 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COMM | 04635X102 | 14,803,575 | 2,761,861 | SH | SOLE | 2,761,861 | 0 | 0 | |||
| AVALO THERAPEUTICS INC | COMM | 05338F306 | 2,410,170 | 483,000 | SH | SOLE | 483,000 | 0 | 0 | |||
| CABALETTA BIO INC | COMM | 12674W109 | 131,928 | 86,795 | SH | SOLE | 86,795 | 0 | 0 | |||
| CIDARA THERAPEUTICS INC | COMM | 171757206 | 48,997,438 | 1,005,901 | SH | SOLE | 1,005,901 | 0 | 0 | |||
| CENTESSA PHARMACEUTICALS PLC | ADRS | 152309100 | 37,985,322 | 2,890,816 | SH | SOLE | 2,890,816 | 0 | 0 | |||
| CG ONCOLOGY INC | COMM | 156944100 | 95,425,356 | 3,670,206 | SH | SOLE | 3,670,206 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COMM | 19240Q201 | 50,004,213 | 6,964,375 | SH | SOLE | 6,964,375 | 0 | 0 | |||
| DIANTHUS THERAPEUTICS INC | COMM | 252828108 | 27,975,255 | 1,501,624 | SH | SOLE | 1,501,624 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COMM | 26818M108 | 35,858,603 | 3,766,660 | SH | SOLE | 3,766,660 | 0 | 0 | |||
| Enliven Therapeutics, Inc. | COMM | 29337E102 | 9,989,880 | 498,000 | SH | SOLE | 498,000 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS INC | COMM | 30233G209 | 33,615,672 | 3,572,335 | SH | SOLE | 3,572,335 | 0 | 0 | |||
| FULCRUM THERAPEUTICS INC | COMM | 359616109 | 36,120,000 | 5,250,000 | SH | SOLE | 5,250,000 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | ADRS | 86366E106 | 22,046,620 | 1,063,000 | SH | SOLE | 1,063,000 | 0 | 0 | |||
| DISC MEDICINE INC | COMM | 254604101 | 24,640,011 | 465,257 | SH | SOLE | 465,257 | 0 | 0 | |||
| JADE BIOSCIENCES INC | COMM | 008064206 | 639,590 | 64,023 | SH | SOLE | 64,023 | 0 | 0 | |||
| KEROS THERAPEUTICS INC | COMM | 492327101 | 0 | 0 | SH | SOLE | 0 | 0 | 0 | |||
| KODIAK SCIENCES INC | COMM | 50015M109 | 4,272,857 | 1,145,538 | SH | SOLE | 1,145,538 | 0 | 0 | |||
| KURA ONCOLOGY INC | COMM | 50127T109 | 4,242,012 | 735,184 | SH | SOLE | 735,184 | 0 | 0 | |||
| MBX BIOSCIENCES INC | COMM | 55287L101 | 7,416,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
| NEKTAR THERAPEUTICS | COMM | 640268306 | 6,890,649 | 266,666 | SH | SOLE | 266,666 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COMM | 67576A100 | 49,361,693 | 5,319,148 | SH | SOLE | 5,319,148 | 0 | 0 | |||
| RAPT Therapeutics, Inc. | COMM | 75382E208 | 13,090,200 | 1,636,275 | SH | SOLE | 1,636,275 | 0 | 0 | |||
| SAVARA INC | COMM | 805111101 | 28,185,827 | 12,362,205 | SH | SOLE | 12,362,205 | 0 | 0 | |||
| SILENCE THERAPEUTICS PLC | ADRS | 82686Q101 | 17,594,648 | 3,033,560 | SH | SOLE | 3,033,560 | 0 | 0 | |||
| SOLENO THERAPEUTICS INC | COMM | 834203309 | 15,604,025 | 186,250 | SH | SOLE | 186,250 | 0 | 0 | |||
| THIRD HARMONIC BIO INC | COMM | 88427A107 | 10,400,752 | 1,915,424 | SH | SOLE | 1,915,424 | 0 | 0 | |||
| TANGO THERAPEUTICS INC | COMM | 87583X109 | 54,968,320 | 10,736,000 | SH | SOLE | 10,736,000 | 0 | 0 | |||
| ENTRADA THERAPEUTICS INC | COMM | 29384C108 | 3,930,898 | 584,955 | SH | SOLE | 584,955 | 0 | 0 | |||
| TOURMALINE BIO INC | COMM | 89157D105 | 23,626,712 | 1,477,593 | SH | SOLE | 1,477,593 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COMM | 90240B106 | 27,734,846 | 2,898,103 | SH | SOLE | 2,898,103 | 0 | 0 | |||
| UPSTREAM BIO INC | COMM | 91678A107 | 30,763,358 | 2,801,763 | SH | SOLE | 2,801,763 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COMM | 92332V107 | 676,657 | 316,195 | SH | SOLE | 316,195 | 0 | 0 | |||
| VISTAGEN THERAPEUTICS INC | COMM | 92840H400 | 5,353,160 | 2,676,580 | SH | SOLE | 2,676,580 | 0 | 0 | |||
| XENCOR INC | COMM | 98401F105 | 19,273,805 | 2,452,138 | SH | SOLE | 2,452,138 | 0 | 0 | |||